| ||||||
| 400 Oyster Point Blvd Ste 505, South San Francisco, CA, 94080-1921, US. TEL: 650-244-4990 http://www.titanpharm.com | ||||||
| Last Sale | Net Change | % Change | Volume | Last Updated | ||
|---|---|---|---|---|---|---|
| $0.03 | 0.00 | 9.09 | 992,602 | 12/24/08 12:59 PM ET | ||
| ||||||||||||||||||||||
 |
|
||||||||||||||||||||||
| ||||
| Security Type | Common Stock | Specialist | 076 | |
| Industry | Health Services, Pharmaceuticals, and Medical Diagnostics | Trading Post | 2 | |
| Primary Exchange | Amex | 0000910267 | ||
| ||||
| Description |
|
Titan Pharmaceuticals, Inc., together with its subsidiaries, operates as a biopharmaceutical company that develops proprietary therapeutics for the treatment of central nervous system disorders, cardiovascular disease, and bone disease. Its products include Probuphine, a Phase III clinical trial product for the treatment of opioid addiction; Iloperidone for the treatment of schizophrenia and related psychotic disorders; and Spheramine, a Phase IIb clinical trial product for the treatment of advanced Parkinson's disease. The company also holds rights to diiodothyropropionic acid, a proprietary product for the treatment of cardiovascular disease; and gallium maltolate, an oral agent for the treatment of chronic bacterial infections, bone disease, and cancer. It has collaboration with Bayer Schering Pharma AG for the development of Spheramine to treat Parkinson's disease; and with Vanda Pharmaceuticals, Inc. to develop iloperidone for the treatment of schizophrenia and related psychotic disorders. The company was founded in 1992 and is based in South San Francisco, California. |
| Quote |
| ||||
| Last Sale | $0.03 (12/24/08) | |||
| Net Change | 0.00 | |||
| % Change | 9.09 | |||
| Previous Close | $0.03 | |||
| Today’s Open | $0.03 | |||
| Today’s High | $0.04 | |||
| Today’s Low | $0.02 | |||
| Volume | 992,602 | |||
| 52 Week High | $1.88 | |||
| 52 Week Low | $0.01 | |||
| ||||
| Chart |
| 3mo | 6mo | 12mo | 24mo | 36mo | 48mo | 60mo |
|
| Click here to view the data behind the chart. |
| Fundamentals |
|
||||
| P/E ratio | 0.00 | Short Interest | N.A. | |
| Earnings Per Share | 0.00 | Current yield | N.A. | |
| Shares Outstanding | 58,288,000 | Dividend Info | ||
| Market Cap | 1,748,640 | |||
|
||||
|
|
